{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:45:18Z","timestamp":1788284718811,"version":"build-2803163510"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/iae.0b013e3181f27509","type":"journal-article","created":{"date-parts":[[2010,10,23]],"date-time":"2010-10-23T06:31:42Z","timestamp":1287815502000},"page":"785-789","source":"Crossref","is-referenced-by-count":7,"title":["INTRAVITREAL CELL-BASED PRODUCTION OF GLUCAGON-LIKE PEPTIDE-1"],"prefix":"10.1097","volume":"31","author":[{"given":"Rong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wallrapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost B","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210130","first-page":"171","article-title":"Teatment of intraocular proliferations with intravitreal steroids.","volume":"77","author":"Machemer","year":"1979","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R2-23-20210130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1600-0420.2005.00592.x","article-title":"Intravitreal triamcinolone acetonide for treatment of intraocular edematous and neovascular diseases.","volume":"83","author":"Jonas","year":"2005","journal-title":"Acta Ophthalmol"},{"key":"R3-23-20210130","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ajo.2004.01.008","article-title":"Serum levels of triamcinolone acetonide after intravitreal injection.","volume":"137","author":"Degenring","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R4-23-20210130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/jop.2006.22.200","article-title":"Intravitreal triamcinolone acetonide for diabetic macular edema. A prospective randomized study.","volume":"22","author":"Jonas","year":"2006","journal-title":"J Ocul Pharmakol Th"},{"key":"R5-23-20210130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archopht.121.5.667","article-title":"A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.","volume":"121","author":"Gillies","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R6-23-20210130","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration.","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"R7-23-20210130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"R9-23-20210130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archopht.122.2.218","article-title":"Intravitreal re-injection of triamcinolone for exudative age-related macular degeneration.","volume":"122","author":"Jonas","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R10-23-20210130","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2004.06.041","article-title":"Safety of intravitreal high-dose re-injections of triamcinolone acetonide.","volume":"138","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R11-23-20210130","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and Neuroprotection.","volume":"9","author":"During","year":"2003","journal-title":"Nat Med"},{"key":"R12-23-20210130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","article-title":"Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy.","volume":"203","author":"Perry","year":"2007","journal-title":"Exp Neurol"},{"key":"R14-23-20210130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neulet.2009.07.071","article-title":"Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury.","volume":"463","author":"Heile","year":"2009","journal-title":"Neuroscience Letters"},{"key":"R15-23-20210130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.119.3.493","article-title":"Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.","volume":"119","author":"Gavrieli","year":"1992","journal-title":"J Cell Biol"},{"key":"R16-23-20210130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/44.9.8773561","article-title":"In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations.","volume":"44","author":"Negoescu","year":"1996","journal-title":"J Histochem Cytochem"},{"key":"R17-23-20210130","first-page":"3292","article-title":"Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.","volume":"43","author":"Tao","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-23-20210130","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1089\/ten.2004.10.1617","article-title":"Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device.","volume":"10","author":"Thanos","year":"2004","journal-title":"Tissue Eng"},{"key":"R19-23-20210130","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1167\/iovs.03-1342","article-title":"Encapsulated cell-based intraocular delivery of ciliary neurotrophic factor in normal rabbit: dose-dependent effects on ERG and retinal histology.","volume":"45","author":"Bush","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-23-20210130","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.0600236103","article-title":"Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants.","volume":"103","author":"Sieving","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R21-23-20210130","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1167\/iovs.09-3741","article-title":"CREB1\/ATF1 activation in photoreceptor degeneration and protection.","volume":"50","author":"Beltran","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-23-20210130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/14712598.6.7.717","article-title":"Application of encapsulated cell technology for retinal degenerative diseases.","volume":"6","author":"Tao","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"R23-23-20210130","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.biomaterials.2008.11.017","article-title":"Drug carrier systems based on collagen-alginate composite structures for improving the performance of GDNF-secreting HEK293 cells.","volume":"30","author":"Lee","year":"2009","journal-title":"Biomaterials"},{"key":"R24-23-20210130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archopht.1990.01070040138048","article-title":"Blindness and visual impairment in an American urban population: the Baltimore Eye Survey.","volume":"108","author":"Tielsch","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"R26-23-20210130","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0b013e3181f27509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:42:26Z","timestamp":1786041746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201104000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181f27509","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}